Artiva Biotherapeutics, Inc. (ARTV) Operating income 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) annual operating income history from SEC filings — each fiscal year as reported.
-$89.8MFY2025 · since FY2023: -$30.7M → -$89.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$89.8M | -33.5% |
| FY2024 | -$67.3M | -119.4% |
| FY2023 | -$30.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice